drugset
drugset / Trial / NCT06593834

A Clinical Study of Bacillus Coagulans in Acute Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation

NCT06593834 ↗

Not yet recruiting 286 enrolled Yamin Fan
RandomizedParallel-groupOpen-labelPrevention

Summary

To evaluate the preventive effect of Bacillus coagulans on acute graft-versus-host disease (aGVHD) after hematopoietic stem cell transplantation

Timeline

Start
2024-09-27
Primary completion
2026-04-30
Completion
2026-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Bacillus coagulans Other / unclassified — —

Indications

acute graft versus host disease